Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Robert F. Sidonio, Jr., MD MSc, Angela C. Weyand, MD, Dunlei Cheng, PhD, Crystal Watson

Blood (2019) 134 (Supplement_1): 1132.

https://doi.org/10.1182/blood-2019-128318

Published: 2019

Journal Articles

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

Jonathan C. Roberts, Lynn M Malec, MD, Imrran Halari, Sarah Hale, Abiola Oladapo, Robert Sidonio

Blood (2019) 134 (Supplement_1): 2117.

https://doi.org/10.1182/blood-2019-122164

Published: 2019

Journal Articles

A Unique Case of Type 3 Von Willebrand Disease

Mamatha Mandava, MD, John Lazarchick, MD, Emily Curl, Shayla Bergmann, MD

Blood (2018) 132 (Supplement 1): 5031.

https://doi.org/10.1182/blood-2018-99-112976

Published: 2018

Journal Articles

Continuous Platelet Transfusion As a Potential Desensitization Regimen in HLA Class I Alloimmune-Mediated Platelet Refractoriness

Jamal Carter, MD, James Szymanski, MD, Cathy Cantilena, MD, Sharon Adams, MT, CHS (ABHI), Shelley Sahu, MD, Willy A. Flegel, MD

Blood (2017) 130 (Supplement 1): 4925.

https://doi.org/10.1182/blood.V130.Suppl_1.4925.4925

Published: 2017

Journal Articles

Splenectomy in a Severe Case of Acquired Factor X Deficiency Secondary to Amyloidosis: Case Discussion and Review of the Literature

Terrence J Bradley, MD, Matthew P Salzberg, MD, George Nahas, DO, Basem Azab, MD, Alan Livingstone, MD, John J. Byrnes, MD, Thomas J. Harrington, MD, James E. Hoffman, MD

Blood (2017) 130 (Supplement 1): 4885.

https://doi.org/10.1182/blood.V130.Suppl_1.4885.4885

Published: 2017

Journal Articles

Phenotype Analysis and Clinical Management in a Large Family with a Novel Truncating Mutation in RASGRP2 , the Caldag-GEFI Encoding Gene

Amrita Desai, MD MPH, Wenche Jy, PhD, Wolfgang Bergmeier, PhD, Mathias Canault, PhD, Marie-Christine Alessi, MD PhD, Paquita Nurden, MD PhD, Yeon-Soong Ahn, MD, Alan T. Nurden, PhD

Blood (2016) 128 (22): 3713.

https://doi.org/10.1182/blood.V128.22.3713.3713

Published: 2016

Journal Articles

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Nicoletta Machin, MD, Margaret V. Ragni, MD MPH, Lynn M. Malec, MD, Donald Brambilla, PhD, Thomas Coyle, MD, Joanna A. Davis, MD, Annette Drygalski, Andra H James, MD MPH, Shawn M Jobe, MD PhD, Barbara A. Konkle, MD, Peter Kouides, MD, Philip Kuriakose, MD, Alice D. Ma, MD, Elaine M. Majerus, MD PhD, Danielle Nance, MD, Anne T. Neff, MD, Claire S. Philipp, MD, Tzu-Fei Wang, MD, Hassan M. Yaish, MD

Blood (2015) 126 (23): 4694.

https://doi.org/10.1182/blood.V126.23.4694.4694

Published: 2015

Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

Michael D Tarantino, MD, James B. Bussel, MD, Victor S. Blanchette, MD FRCP, Jenny M. Despotovic, DO, MS, Carolyn Bennett, Ashok Raj, MD, Bronwyn Williams, Donald Beam, Jaime Morales, Melissa J. Rose, DO, Kun Nie, Melissa Eisen, MD

Blood (2015) 126 (23): 3467.

https://doi.org/10.1182/blood.V126.23.3467.3467

Published: 2015

Journal Articles

Large Cohort of Symptomatic Female Carriers of Hemophilia in an Extended Native American Family

Becki Berkowitz, RN, CPON, Amber Federizo, RN, MSN, FNP-BC, Garrett E. Bergman, MD MBA, Paula J. Ulsh, RN, BSN

Blood (2015) 126 (23): 4700.

https://doi.org/10.1182/blood.V126.23.4700.4700

Published: 2015

Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Michael D. Tarantino, Amy Geddis, Michael F. Guerrera, Alan K. Ikeda, Kun Nie, Janet Franklin, Melissa Eisen

Blood (2014) 124 (21): 4184.

https://doi.org/10.1182/blood.V124.21.4184.4184

Published: 2014

Journal Articles

Aminocaproic Acid Use in Patients with Hematologic Malignancy: A Case Series

Ariela L. Marshall, MD, Ang Li, MD, Adrienne Drucker, PharmD, Walter Sunny Dzik, MD

Blood (2014) 124 (21): 4292.

https://doi.org/10.1182/blood.V124.21.4292.4292

Published: 2014

Journal Articles

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

Joan Beckman, MDPhD, Karen L Smith, BS, Samuel T Hester, MD, Ofri Leitner, MS, CGC, Raj S. Kasthuri, MD MBBS

Blood (2014) 124 (21): 1515.

https://doi.org/10.1182/blood.V124.21.1515.1515

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation without Hematopoietic Support for the Treatment of Hematological Malignancies in 125 Jehovah’s Witnesses

Shakira Jeanene Grant, MBBS, Patricia Ford, MD, Rosemarie Mick, MS, Gina Keck, RN

Blood (2014) 124 (21): 3976.

https://doi.org/10.1182/blood.V124.21.3976.3976

Published: 2014

Journal Articles

Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Michael D. Tarantino, MD, James B. Bussel, MD, Amy Geddis, MD, Michael F. Guerrera, MD, Alan K. Ikeda, MD, Kun Nie, PhD, Melissa Eisen, MD

Blood (2013) 122 (21): 3530.

https://doi.org/10.1182/blood.V122.21.3530.3530

Published: 2013

Journal Articles

Hemorrhagic Complications With Adenotonsillectomy In Children and Young Adults With Bleeding Disorders

Deepti M. Warad, M.B.B.S., Fareeda TN. Hussain, MD, Shelagh A. Cofer, MD, Vilmarie Rodriguez, MD

Blood (2013) 122 (21): 3611.

https://doi.org/10.1182/blood.V122.21.3611.3611

Published: 2013

Journal Articles

Massive Transfusion in Non-Trauma Patients,

Lisa M Baumann Kreuziger, MD, Josh Salzman, MA, Amar T Subramanian, MD, Colleen T. Morton, MBBS, David J Dries, MD

Blood (2011) 118 (21): 3376.

https://doi.org/10.1182/blood.V118.21.3376.3376

Published: 2011

Journal Articles

Outcomes of High Dose Steroid Treatment with or without Aminocaproic Acid in Critically Ill Stem Cell Transplant Recipients with Diffuse Alveolar Hemorrhage

Nisha Rathi, M.D., Andrew Dinh, BS, Sajid A. Haque, M.D., Lei Feng, Ph.D, Suyu Liu, Wenli Dong, Joseph L Nates, M.D., Kristen J Price, M.D., Uday Popat, M.D.

Blood (2011) 118 (21): 3058.

https://doi.org/10.1182/blood.V118.21.3058.3058

Published: 2011

Journal Articles

Bevacizumab Rapidly and Completely Corrects Massive Transfusion Requirement In a Patient with Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Donald Busiek, MD, Keith Bernstein, M.D.

Blood (2010) 116 (21): 2118.

https://doi.org/10.1182/blood.V116.21.2118.2118

Published: 2010

Journal Articles

Splenic Rupture as a Complication of Autologous Hematopoietic Cell Transplantation In a Patient with Systemic Amyloidosis.

Taiga Nishihori, MD, Noman Ashraf, MD, Estrella M. Carballido, MD, Timothy Yeatman, M.D., Lynn C. Moscinski, MD, Melissa Alsina, MD

Blood (2010) 116 (21): 4528.

https://doi.org/10.1182/blood.V116.21.4528.4528

Published: 2010

Journal Articles

Transforming Transfusion Practices: High Dose Aminocaproic Acid and Vitamin K for the Management of Thrombocytopenia

Suzanne Rossi, BA, Patricia A. Locantore-Ford, MD, Lawrence D Jones, RPh

Blood (2008) 112 (11): 4547.

https://doi.org/10.1182/blood.V112.11.4547.4547

Published: 2008

NARROW

Assessing the Safety of Various VWF Regimens in Patients with Clinically Severe VWD: A Natural History Study

Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database

A Unique Case of Type 3 Von Willebrand Disease

Continuous Platelet Transfusion As a Potential Desensitization Regimen in HLA Class I Alloimmune-Mediated Platelet Refractoriness

Splenectomy in a Severe Case of Acquired Factor X Deficiency Secondary to Amyloidosis: Case Discussion and Review of the Literature

Phenotype Analysis and Clinical Management in a Large Family with a Novel Truncating Mutation in RASGRP2 , the Caldag-GEFI Encoding Gene

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

Large Cohort of Symptomatic Female Carriers of Hemophilia in an Extended Native American Family

Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)

Aminocaproic Acid Use in Patients with Hematologic Malignancy: A Case Series

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

Autologous Stem Cell Transplantation without Hematopoietic Support for the Treatment of Hematological Malignancies in 125 Jehovah’s Witnesses

Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Hemorrhagic Complications With Adenotonsillectomy In Children and Young Adults With Bleeding Disorders

Massive Transfusion in Non-Trauma Patients,

Outcomes of High Dose Steroid Treatment with or without Aminocaproic Acid in Critically Ill Stem Cell Transplant Recipients with Diffuse Alveolar Hemorrhage

Bevacizumab Rapidly and Completely Corrects Massive Transfusion Requirement In a Patient with Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Splenic Rupture as a Complication of Autologous Hematopoietic Cell Transplantation In a Patient with Systemic Amyloidosis.

Transforming Transfusion Practices: High Dose Aminocaproic Acid and Vitamin K for the Management of Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only